Related Experiment Video

Updated: May 17, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2

Chao Zhang1, Yong Liang Chi, Ping Yu Wang

  • 1Key Laboratory of Tumour Molecular Biology in Binzhou Medical University, Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, ShanDong, PR China.

Plos One
|October 17, 2012
PubMed

Insights

MicroRNAs (miRNAs) miR-511 and miR-1297 suppress adenocarcinoma cell proliferation by targeting the TRIB2 oncogene. This leads to increased C/EBPα expression, identifying these miRNAs as potential tumor suppressors.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in various diseases, including cancer.
  • The TRIB2 oncogene plays a role in human cancers, and its regulation by miRNAs is an area of active research.

Purpose of the Study:

  • To investigate the role of miR-511 and miR-1297 in adenocarcinoma.
  • To determine if miR-511 and miR-1297 directly interact with and regulate the TRIB2 oncogene.
  • To assess the functional impact of this interaction on cancer cell proliferation and apoptosis.

Main Methods:

  • Bioinformatics analysis to predict miRNA binding sites on TRIB2.
  • Construction of a pcDNA-GFP-TRIB2-3'UTR vector for interaction studies.
  • Co-transfection of A549 adenocarcinoma cells with miRNAs and the vector.
  • Assessment of GFP expression via fluorescence microscopy and flow cytometry.
  • Western blotting to confirm TRIB2 downregulation.
  • MTT assays for cell proliferation and Annexin V-FITC/PI staining for apoptosis analysis.

Main Results:

  • miR-511 and miR-1297 significantly downregulated GFP expression, indicating interaction with TRIB2.
  • Western blot analysis confirmed decreased TRIB2 expression in cells treated with miR-511 and miR-1297.
  • MTT assays showed inhibited A549 cell proliferation, and Annexin V-FITC/PI staining revealed increased apoptosis.
  • Expression of the downstream transcription factor C/EBPα was elevated following TRIB2 suppression.

Conclusions:

  • miR-511 and miR-1297 function as tumor suppressor miRNAs in the A549 adenocarcinoma cell line.
  • These miRNAs inhibit cell proliferation and promote apoptosis by targeting TRIB2 and subsequently increasing C/EBPα expression.
  • miR-511 and miR-1297 represent potential therapeutic targets for adenocarcinoma treatment.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...